Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians-Reference-Cited by-同舟云学术

Optimizing the management of castration‐resistant prostate cancer patients: A practical guide for clinicians

Published:2020-08-11 Issue:14 Volume:80 Page:1159-1176
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Shore Neal D.¹^ORCID,Drake Charles G.²^ORCID,Lin Daniel W.³^ORCID,Ryan Charles J.⁴^ORCID,Stratton Kelly L.⁵^ORCID,Dunshee Curtis⁶^ORCID,Karsh Lawrence I.⁷^ORCID,Kaul Sanjeev⁸,Kernen Ken⁹,Pieczonka Christopher¹⁰^ORCID,Sieber Paul¹¹,Stewart Christopher¹²,Williams Michael¹³,Concepcion Raoul S.¹⁴¹⁵^ORCID

Affiliation:

1. Carolina Urologic Research CenterAtlantic Urology ClinicsMyrtle Beach South Carolina

2. Columbia UniversityNew York New York

3. University of WashingtonSeattle Washington

4. Division of Hematology, Oncology, and TransplantationUniversity of MinnesotaMinneapolis Minnesota

5. Department of UrologyUniversity of Oklahoma Health Sciences CenterOklahoma City Oklahoma

6. Urological Associates of Southern ArizonaTucson Arizona

7. The Urology Center of ColoradoDenver Colorado

8. Michigan Healthcare ProfessionalsTroy Michigan

9. Michigan Institute of UrologyDetroit Michigan

10. Associated Medical Professionals of New YorkSyracuse New York

11. Keystone Urology SpecialistsLancaster Pennsylvania

12. Arizona Urology SpecialistsGlendale Arizona

13. Urology of VirginiaNorfolk Virginia

14. Integra ConnectWest Palm Beach Florida

15. Department of UrologyVanderbilt University School of MedicineNashville Tennessee

Funder

Tolmar Pharmaceuticals

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24053

Reference54 articles.

1. Cancer Risks in BRCA2 Mutation Carriers

2. Germline and Somatic Mutations in Prostate Cancer for the Clinician

3. Germline testing in those at risk of prostate cancer;Carroll PR;Can J Urol,2019

4. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines). Prostate Cancer. Evidence Blocks. Version 1. 2020.https://www.nccn.org/. Accessed April 15 2020.

5. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival after docetaxel for metastatic castration-resistant prostate cancer in a rural health care setting;Współczesna Onkologia;2024

2. Guidelines for genetic testing in prostate cancer: a scoping review;Prostate Cancer and Prostatic Diseases;2023-05-18

3. Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration‐resistant prostate cancer;Cancer Medicine;2023-02-07

4. A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1;Cell Death & Disease;2023-01-06

5. Exploring the therapeutic potential of Neem (Azadirachta Indica) for the treatment of prostate cancer: a literature review;Annals of Translational Medicine;2022-07